Skip to main content

ACACIA RESEARCH CORP

For the period ended Jun 30, 2025. Filed Aug 7, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 7, 2025

ACTG$4.25+0.2%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 2.

Operating Expenses

Three Months EndedJune 30,Six Months EndedJune 30,
20252024$ Change% Change20252024$ Change% Change
(In thousands, except percentage change values)
Sales and marketing expenses - industrial operations$1,244$1,387$(143)(10%)$2,809$2,942$(133)(5%)
Sales and marketing expenses - manufacturing operations2,137—2,137n/a3,884—3,884n/a
General and administrative costs - intellectual property operations1,3841,821(437)(24%)4,8695,161(292)(6%)
General and administrative costs - industrial operations1,8681,905(37)(2%)3,6113,930(319)(8%)
General and administrative costs - energy operations915883324%2,5221,2681,25499%
General and administrative costs - manufacturing operations5,066—5,066n/a10,774—10,774n/a
Parent general and administrative expenses6,3135,52079314%11,09012,257(1,167)(10%)
Total general and administrative expenses15,54610,1295,41753%32,86622,61610,25045%
Total$18,927$11,516$7,41164%$39,559$25,558$14,00155%

The operating expenses table above includes the Company’s general and administrative and sales and marketing expenses by operation. The table also includes Manufacturing Operations sales and marketing expenses and general and administrative costs for the three and six months ended June 30, 2025, with no comparable prior year period information as the Deflecto Transaction closed in October 2024. Refer to Note 2 to the consolidated financial statements elsewhere herein for additional information regarding Printronix’s and Deflecto’s operating expenses.

General and Administrative Expenses

A summary of the main drivers of the increases (decreases) in general and administrative expenses is as follows:

Three Months EndedJune 30,Six Months EndedJune 30,
2025 vs. 20242025 vs. 2024
(In thousands)
Personnel costs and board fees$88$(10)
Variable performance-based compensation costs37291
Other general and administrative costs373(1,664)
General and administrative costs - industrial operations(39)(321)
General and administrative costs - energy operations321,254
General and administrative costs - manufacturing operations4,6399,875
Amortization of industrial operations intangible assets—2
Amortization of manufacturing operations intangible assets427899
Compensation expense for share-based awards63127
Non-recurring employee severance costs(203)(203)

General and administrative expenses include employee compensation and related personnel costs, including variable performance based compensation and compensation expense for share-based awards, office and facilities costs, legal and accounting professional fees, public relations, stock administration, business development, fixed asset depreciation, amortization of Industrial Operations and Manufacturing Operations’ intangible assets, and other corporate costs. The periods presented above include an increase in Energy Operations’ general administrative expenses for the quarter following our acquisition of Revolution in April 2024. The table above also includes our Manufacturing Operations general and administrative expenses for the three and six months ended June 30, 2025, with no comparable period expense as the transaction closed in October 2024.

The increase in variable performance-based compensation costs was primarily due to an increase in bonuses paid on Intellectual Property Operations revenues. The decrease in other general and administrative costs for the six month period, which relates to our parent company and our Intellectual Property Operations, were primarily due to a decrease in corporate legal fees. The increase in compensation expense for share-based awards was primarily due to compensation expense incurred related to PSUs granted in 2023 based on a probability assessment regarding their vesting performed as of June 30, 2025. Refer to Note 17 to the consolidated financial statements elsewhere herein for additional information regarding compensation expense. The decrease in general and administrative costs of Industrial Operations is due to Printronix’s initiative to reduce costs and operate more efficiently. In addition, our Energy Operations related general and administrative costs contributed an increase of $1.3 million and Manufacturing Operations related general and administrative costs and amortization of intangible assets contributed $9.9 million and $0.9 million, respectively, in each case driven by the acquisitions of Revolution and Deflecto in 2024. Refer to additional general and administrative change explanations above.

Other Income/Expense

Equity Securities Investments

Three Months EndedJune 30,Six Months EndedJune 30,
20252024$ Change% Change20252024$ Change% Change
(In thousands, except percentage change values)
Change in fair value of equity securities$2,219$(4,744)$6,963(147%)$(2,558)$(31,445)$28,887(92%)
Gain on sale of equity securities1,907—1,907n/a3,51228,861(25,349)(88%)
Total net realized and unrealized gain (loss)$4,126$(4,744)$8,870(187%)$954$(2,584)$3,538(137%)

Our equity securities investments, including the Life Sciences Portfolio and trading securities portfolio, are recorded at fair value at each balance sheet date. During the first quarter of 2024, Acacia fully exited its position in Arix. Refer to periodic change explanations above. Refer to Notes 2 and 4 to the consolidated financial statements elsewhere herein for additional information regarding our investment in the Life Sciences Portfolio and other equity securities.

Our results included unrealized gains and losses from the change in fair value of our equity securities, and included realized gains from the sale of our equity securities. These changes were derived from our Life Sciences Portfolio and trading securities portfolio. The 2024 period unrealized loss and realized gain primarily relates to the sale of Arix shares.

Non-recurring legacy legal expense

Three Months EndedJune 30,Six Months EndedJune 30,
20252024$ Change% Change20252024$ Change% Change
(In thousands, except percentage change values)
Non-recurring legacy legal expense$—$(6,613)$6,613(100%)$—$(12,856)$12,856(100%)

Non-recurring legacy legal expense incurred in the three and six month period June 30, 2024 is related to a dispute involving former executives (the “AIP Matter”). There were no comparable expenses for the three and six months ended June 30, 2025.

Income Taxes

Three Months EndedJune 30,Six Months EndedJune 30,
20252024$ Change% Change20252024$ Change% Change
(In thousands, except percentage change values)
Income tax (expense) benefit$(547)$7,061$(7,608)(108%)$(6,628)$8,170$(14,798)(181%)
Effective tax rate61%(44)%n/a105%(23)%(48)%n/a25%

Our 2025 effective tax rate was slightly higher than the U.S. federal statutory rate primarily due to nondeductible stock based compensation.

Our income tax expense for the three months ended June 30, 2025 is primarily attributable to additional year-to date tax expense related to decreased benefit from non-controlling interest income from subsidiaries. Our income tax expense for the six months ended June 30, 2025 is primarily attributable to the statutory rate applied to our year-to date earnings and foreign withholding taxes for which a foreign tax credit cannot be benefited.

Our 2024 effective tax rate in each period was higher than the U.S. federal statutory rate primarily due to favorable permanent book tax differences offset by foreign withholding taxes, which we could not recognize as a foreign tax credit. Our income tax benefit for the three and six months ended June 30, 2024 is primarily attributable to recognizing an income tax benefit on losses incurred offset by foreign withholding taxes.

The effective tax rate may be subject to fluctuations during the year as new information is obtained which may affect the assumptions used to estimate the effective tax rate, including factors such as expected utilization of net operating loss carryforwards, changes in or the interpretation of tax laws in jurisdictions where the Company conducts business, the Company’s expansion into new states or foreign countries, and the amount of valuation allowances against deferred tax assets.

The Company has recorded a partial valuation allowance against our net deferred tax assets as of June 30, 2025 and December 31, 2024 on foreign tax credits and certain state net operating losses.

At June 30, 2025 and December 31, 2024, the Company had total unrecognized tax benefits of approximately $935,000. At June 30, 2025 and December 31, 2024, $935,000 of unrecognized tax benefits were recorded in other long-term liabilities. No interest and penalties have been recorded for the unrecognized tax benefits for the periods presented. At June 30, 2025, if recognized, $935,000 of tax benefits would impact the Company’s effective tax rate subject to valuation allowance. The Company does not expect that the long-term liability for unrecognized benefits will change significantly within the next 12 months. The Company recognizes interest and penalties with respect to unrecognized tax benefits in income tax expense (benefit).

On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the U.S. The OBBBA includes significant provisions, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, modifications to the international tax framework and the restoration of favorable tax treatment for certain business provisions. The legislation has multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. The Company is currently assessing its impact on our consolidated financial statements.

Liquidity and Capital Resources

General

Our foreseeable material cash requirements as of June 30, 2025, are recognized as liabilities or generally are otherwise described in Note 15, “Commitments and Contingencies,” to the consolidated financial statements included elsewhere herein. In particular, our facilities lease obligations, guarantees and certain contingent obligations are further described in Note 15 to the accompanying consolidated financial statements. Historically, we have not entered into off-balance sheet financing arrangements. In addition, the obligations of our Energy Operations Business related to the Benchmark Revolving Credit Facility and the obligations of our Manufacturing Operations Business related to the Deflecto Term Loan are further described in Note 11 to the accompanying consolidated financial statements. The obligations of our Energy Operations Business related to the asset retirement obligations are further described in Note 10 to the accompanying consolidated financial statements.

Additional cash requirements are generally derived from our operating and investing activities including expenditures for working capital (discussed below), human capital, business development, investments in equity securities and intellectual property, and business combinations.

Certain of our operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In connection with any of our operating subsidiaries’ patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against us or our operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material.

At June 30, 2025, our primary sources of liquidity were cash and cash equivalents on hand and cash generated from our operating activities.

Furthermore, we intend to grow our company by acquiring additional operating businesses and intellectual property assets. We expect to finance such acquisitions through cash on hand or by engaging in equity or debt financing.

Our management believes that our cash and cash equivalent balances and cash flows from operations will be sufficient to meet our cash requirements through at least twelve months from the date of this Quarterly Report and for the foreseeable future. We may, however, encounter unforeseen difficulties that may deplete our capital resources more rapidly than anticipated, including those set forth under Item 1A, “Risk Factors” in our 2024 Annual Report and Part II, Item 1A, “Risk Factors” in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2025. Any efforts to seek additional funding could be made through issuances of equity or debt, or other external financing. However, additional funding may not be available to us on favorable terms, or at all. The capital and credit markets have experienced extreme volatility and disruption in recent years, and the volatility and impact of the disruption may continue. At times during this period, the volatility and disruption has reached unprecedented levels. In several cases, the markets have exerted downward pressure on stock prices and credit capacity for certain issuers, and the commercial paper markets may not be a reliable source of short-term financing for us. If we fail to obtain additional financing when needed, we may not be able to execute our business plans and our business, conducted by our operating subsidiaries, may suffer.

Cash, Cash Equivalents and Investments

Our consolidated cash, cash equivalents and equity securities totaled $338.2 million at June 30, 2025, compared to $297.0 million at December 31, 2024.

The Benchmark Revolving Credit Facility and Deflecto Revolving Credit Facility include covenants potentially limiting our borrowing capacity as determined by a leverage ratio. As of June 30, 2025, we were in compliance with all financial covenants applicable to the Benchmark Revolving Credit Facility. As of June 30, 2025, we were in compliance with all financial covenants applicable to the Defelcto Revolving Credit Facility. Refer to Note 11 to the accompanying consolidated financial statements for additional information.

Cash Flows Summary

The net change in cash and cash equivalents for the periods presented was comprised of the following:

Six Months Ended June 30,
20252024
(In thousands)
Net cash (used in) provided by:
Operating activities$52,545$70,977
Investing activities(451)(109,833)
Financing activities(10,340)85,880
Effect of exchange rates on cash and cash equivalents1,087(127)
Increase in cash and cash equivalents$42,841$46,897

Cash Flows from Operating Activities

Cash flows from operating activities were comprised of the following for the periods presented:

Six Months Ended June 30,
20252024
(In thousands)
Net income (loss) including noncontrolling interests in subsidiaries$22,091$(9,018)
Adjustments to reconcile net loss including noncontrolling interests in subsidiaries to net cash provided by operating activities:
Depreciation, depletion and amortization22,05511,973
Amortization of debt discount and issuance costs95—
Accretion of asset retirement obligation867254
Compensation expense for share-based awards1,8761,749
(Gain) loss on foreign currency exchange(435)202
Change in fair value of equity securities2,55831,445
Gain on sale of equity securities(3,512)(28,861)
Unrealized (gain) loss on derivatives(789)3,401
Deferred income taxes3,646(10,939)
Changes in assets and liabilities:
Accounts receivable3,50161,727
Inventories1,760(1,368)
Prepaid expenses and other assets(4,114)(3,949)
Accounts payable and accrued expenses2,55120,437
Royalties and contingent legal fees payable231(5,917)
Deferred revenue164(159)
Net cash provided by operating activities$52,545$70,977

Cash receipts from ARG’s licensees totaled $70.3 million and $87.4 million for the six months ended June 30, 2025 and 2024, respectively. Cash receipts from Printronix’s customers totaled $15.7 million and $16.3 million for the six months ended June 30, 2025 and 2024, respectively. Cash receipts from Benchmark’s customers totaled $54.5 million and $15.3 million for the six months ended June 30, 2025 and 2024, respectively. Cash receipts from Deflecto’s customers totaled $57.4 million for the six months ended June 30, 2025. The fluctuations in cash receipts for the periods presented primarily reflects the corresponding fluctuations in revenues recognized during the same periods, as described above, and the related timing of payments received from licensees and customers.

Our reported cash provided by operations for the six months ended June 30, 2025 was $52.5 million, compared to $71.0 million in the comparable prior year period. The decrease in cash provided by operations was primarily due to net inflows from the total changes in assets and liabilities (refer to Working Capital discussion below), decrease in accounts receivable, decrease in inventories, decrease in prepaid expense and other assets, decrease in accounts payable, increase in royalties and contingent legal fees payable and by the total change in net income (described above) and related noncash adjustments.

Working Capital

Our working capital related to cash flows from operating activities at June 30, 2025 decreased to $18.6 million, compared to $36.7 million at December 31, 2024, which was comprised of the changes in assets and liabilities presented above. The decrease is primarily due to the change in accounts receivable and prepaid expenses, which is related to the timing of the cash receipts related to Intellectual Property Operations Business.

Cash Flows from Investing Activities

Cash flows from investing activities were comprised of the following for the periods presented:

Six Months Ended June 30,
20252024
(In thousands)
Acquisition, net of cash acquired and working capital adjustments (Note 3)$1,230$—
Patent acquisition—(9,000)
Purchases of equity securities(12,543)(15,544)
Sales of equity securities15,16557,854
Purchases of property and equipment(940)(508)
Net additions to oil and gas properties(3,363)(142,635)
Net cash used in investing activities$(451)$(109,833)

Cash outflows from investing activities for the six months ended June 30, 2025 was $0.5 million, as compared to cash outflows of $109.8 million in the prior year, primarily due to the 2024 net cash outflows related to the acquisition of the Revolution assets offset by cash inflows from the sale of Arix shares.

Cash Flows from Financing Activities

Cash flows from financing activities included the following for the periods presented:

Six Months Ended June 30,
20252024
(In thousands)
Contributions from noncontrolling interest$—$15,250
Borrowings on the Benchmark revolving credit facility—71,475
Paydown of Benchmark revolving credit facility(8,500)—
Paydown of Deflecto term loan(1,200)—
Taxes paid related to net share settlement of share-based awards(670)(1,068)
Proceeds from exercise of stock options30223
Net cash (used in) provided by financing activities$(10,340)$85,880

Cash outflows from financing activities for the six months ended June 30, 2025 were $10.3 million, as compared to cash inflows of $85.9 million in the prior year, primarily due to borrowings on the revolving credit facility in the prior year which did not recur during the six months ended June 30, 2025 and paydowns on the Benchmark Revolving Credit Facility and Deflecto Term Loan during the six months ended June 30, 2025. Refer to Note 11 to the consolidated financial statements elsewhere herein for additional information regarding the Benchmark Revolving Credit Facility and Deflecto Term Loan.

Critical Accounting Estimates

Our consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America. In preparing these financial statements, we make assumptions, judgments and estimates that involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on our financial condition or results of operations. We base our assumptions, judgments and estimates on historical experience and various other factors that we believe to be reasonable under the circumstances. Actual results could differ materially from these estimates under different assumptions or conditions. On a regular basis, we evaluate our assumptions, judgments and estimates and make changes accordingly.

We believe that of the significant accounting policies discussed in Note 2 included in our 2024 Annual Report, the following accounting policies require our most difficult, subjective or complex assumptions, judgments and estimates:

revenue recognition;

estimates of crude oil and natural gas reserves;

valuation of long-lived assets, goodwill and other intangible assets; and

accounting for income taxes.

Our critical accounting estimates have not changed materially from those disclosed in the Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our 2024 Annual Report. For further information on the significant accounting policies related to the revenue recognition, estimates of crude oil and natural gas reserves, valuation of long-lived assets, goodwill and other intangible assets and income taxes, refer to Note 2 to the consolidated financial statements and other related significant accounting policies included in our 2024 Annual Report.

Recent Accounting Pronouncements

The effects of accounting standards adopted in 2024 and the potential effects of accounting standards to be adopted in the future are described in Note 2 to consolidated financial statements included elsewhere herein.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.